James Clough, DPM
Podiatrist · Polson, MTNPI 1013999846
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,566 of the $2,315 with a category attached, or 67.6%. 14 manufacturers reported payments, led by Paragon 28, Inc. at 37.8% of the total. Reporting peaked in 2019 at $1,112 and has fallen 75.5% since, to $272 in 2024.
Across 22 payments — averaging $105.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Paragon 28, Inc.$876
- Treace Medical Concepts, Inc.$780
- Integra Lifesciences Corporation$245
- Trilliant Surgical LLC.$132
- Medtronic$107
- Organogenesis Inc.$31
- plus $144 from 8 others
What the payments were for
- Travel & lodging$1,56668%
- Food & beverage$50422%
- Other$24511%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Paragon 28, Inc. | 6 | $876 |
| Treace Medical Concepts, Inc. | 2 | $780 |
| Integra Lifesciences Corporation | 1 | $245 |
| Trilliant Surgical LLC. | 1 | $132 |
| Medtronic(2 entities) | 2 | $107 |
| Organogenesis Inc. | 2 | $31 |
| Neurocrine Biosciences, Inc. | 1 | $27 |
| Novo Nordisk | 1 | $24 |
| Pfizer | 1 | $20 |
| Smith+Nephew | 1 | $17 |
| Ultragenyx Pharmaceutical Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $14 |
| Boehringer Ingelheim | 1 | $14 |
| Averitas Pharma Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lapiplasty System$780
- ACell$245
- MIB$132
- Cellerate$132
How this compares
Too few podiatrist providers in Montanato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pregabalin | 13 | $135 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Polson
- Shawn BraunagelBillings$34K
- Trent LottLewistown$8K
- Kevin KundisGreat Falls$4K
- David EkmanBillings$4K
- Katie Kovacich SmithFort Harrision$3K
- Peter JenningsDillon$3K
- Anthony QuebedeauxHelena$224
- Philip SchrumpfMissoula$172
- Justin HookerShelby$34
- Bruce FisherGreat Falls$13
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.